Chronic treatment with haloperidol diminishes the phencyclidine-induced sensorimotor gating deficit in rats

被引:0
|
作者
Ma∏gorzata Pietraszek
Krystyna Ossowska
机构
[1] Department of Neuro-Psychopharmacology,
[2] Institute of Pharmacology,undefined
[3] Polish Academy of Sciences,undefined
[4] 12 Sm´tna St.,undefined
[5] PL-31-343 Kraków,undefined
[6] Poland,undefined
关键词
Key words Prepulse inhibition; Phencyclidine; Chronic haloperidol; Antipsychotic action;
D O I
暂无
中图分类号
学科分类号
摘要
Prepulse inhibition is a model in which a weak subthreshold stimulus (prepulse), presented to an individual before a strong stimulus (pulse), inhibits a startle response to the latter. A deficit of prepulse inhibition induced by dopaminomimetics and antagonists of NMDA receptors has been suggested as an animal model of the sensorimotor deficit in schizophrenia. The aim of the present study was to examine the effect of chronic treatment with the classic neuroleptic haloperidol on the disruption of prepulse inhibition induced by the uncompetitive antagonist of NMDA receptors phencyclidine (PCP, 5mg/kg sc). Haloperidol in a dose of 1mg/kg/day was given to rats in drinking water for 3 months. The PCP-induced reduction in prepulse inhibition was not reversed by short-term (4-day) haloperidol administration. In contrast, long-term treatment with haloperidol (6 weeks or 3 months) diminished the PCP-induced effect. The present study suggests that the improvement in sensorimotor gating in the PCP model in rats by prolonged treatment with haloperidol may reflect its antipsychotic action.
引用
收藏
页码:466 / 471
页数:5
相关论文
共 50 条
  • [1] Chronic treatment with haloperidol diminishes the phencyclidine-induced sensorimotor gating deficit in rats
    Pietraszek, M
    Ossowska, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : 466 - 471
  • [2] The effect of chronic haloperidol administration on cortical NMDA receptors and the phencyclidine-induced sensorimotor gating deficit in rats
    Pietraszek, M
    Wardas, J
    Wolfarth, S
    Ossowska, K
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 : 425 - 425
  • [3] Early and "late" effects of sustained haloperidol on apomorphine- and phencyclidine-induced sensorimotor gating deficits
    Martinez, ZA
    Oostwegel, J
    Geyer, MA
    Ellison, GD
    Swerdlow, NR
    NEUROPSYCHOPHARMACOLOGY, 2000, 23 (05) : 517 - 527
  • [4] “Early” and “Late” Effects of Sustained Haloperidol on Apomorphine- and Phencyclidine-induced Sensorimotor Gating Deficits
    Zoë A Martinez
    Jeff Oostwegel
    Mark A Geyer
    Gaylord D Ellison
    Neal R Swerdlow
    Neuropsychopharmacology, 2000, 23 : 517 - 527
  • [5] Influence of long-lasting administration of neuroleptics on cortical NMDA receptors and phencyclidine-induced deficit in the sensorimotor gating in rats
    Ossowska, K
    Pietraszek, M
    Wardas, J
    Nowak, G
    Wolfarth, S
    POLISH JOURNAL OF PHARMACOLOGY, 1999, 51 (01): : 49 - 53
  • [6] Influence of CGS 21680, a selective adenosine A2A agonist, on the phencyclidine-induced sensorimotor gating deficit and motor behaviour in rats
    Wardas, J
    Konieczny, J
    Pietraszek, M
    PSYCHOPHARMACOLOGY, 2003, 168 (03) : 299 - 306
  • [7] Influence of CGS 21680, a selective adenosine A2A agonist, on the phencyclidine-induced sensorimotor gating deficit and motor behaviour in rats
    Jadwiga Wardas
    Jolanta Konieczny
    Małgorzata Pietraszek
    Psychopharmacology, 2003, 168 : 299 - 306
  • [8] Sustained haloperidol opposes apomorphine and phencyclidine-induced startle gating deficits
    Martinez, ZA
    Oostwegel, J
    Geyer, MA
    Ellison, GD
    Swerdlow, NR
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 36S - 36S
  • [9] CLOZAPINE ANTAGONIZES, PHENCYCLIDINE-INDUCED DEFICITS IN SENSORIMOTOR GATING OF THE STARTLE RESPONSE
    BAKSHI, VP
    SWERDLOW, NR
    GEYER, MA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 271 (02): : 787 - 794
  • [10] PHENCYCLIDINE-INDUCED DOPAMINE-DEPENDENT BEHAVIORS IN CHRONIC HALOPERIDOL-TREATED RATS
    YAMAGUCHI, K
    NABESHIMA, T
    AMANO, M
    YOSHIDA, S
    FURUKAWA, H
    KAMEYAMA, T
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1985, 23 (05) : 803 - 809